Investigational Drug Information for Givinostat
✉ Email this page to a colleague
What is the drug development status for Givinostat?
Givinostat is an investigational drug.
There have been 16 clinical trials for Givinostat.
The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2017.
The most common disease conditions in clinical trials are Muscular Dystrophy, Duchenne, Muscular Dystrophies, and Arthritis, Juvenile. The leading clinical trial sponsors are Italfarmaco, Parexel, and inVentiv Health Clinical.
There are one hundred and forty-four US patents protecting this investigational drug and one international patent.
Summary for Givinostat
| US Patents | 144 |
| International Patents | 1,517 |
| US Patent Applications | 526 |
| WIPO Patent Applications | 464 |
| Japanese Patent Applications | 88 |
| Clinical Trial Progress | Phase 2 (2017-06-01) |
| Vendors | 39 |
Recent Clinical Trials for Givinostat
| Title | Sponsor | Phase |
|---|---|---|
| Perpetrator DDI Potential of Givinostat as Inhibitor and Inducer of CYP3A and P-gp Activity | Italfarmaco | Phase 1 |
| The Potential of Givinostat as DDI Victim in Co-administration P-gp Inhibitor (Part 2) | Italfarmaco | Phase 1 |
| Givinostat and Metabolites Pharmacokinetics in Urine and Plasma (Part 3) | Italfarmaco | Phase 1 |
Clinical Trial Summary for Givinostat
Top disease conditions for Givinostat
Top clinical trial sponsors for Givinostat
US Patents for Givinostat
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Givinostat | ⤷ Try a Trial | Histone deacetylase inhibitors and methods for use thereof | REACTION BIOLOGY CORP. (Malvern, PA) | ⤷ Try a Trial |
| Givinostat | ⤷ Try a Trial | Anti-CS1 antibodies and antibody drug conjugates | AbbVie Biotherapeutics Inc. (Redwood City, CA) | ⤷ Try a Trial |
| Givinostat | ⤷ Try a Trial | Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections | EMORY UNIVERSITY (Atlanta, GA) | ⤷ Try a Trial |
| Givinostat | ⤷ Try a Trial | Antibody drug conjugates (ADCs) with kinesin spindel protein (KSP) | BAYER PHARMA AKTIENGESELLSCHAFT (Berlin, DE) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Givinostat
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Givinostat | World Intellectual Property Organization (WIPO) | WO2017030892 | 2035-08-14 | ⤷ Try a Trial |
| Givinostat | Australia | AU2015339012 | 2034-10-31 | ⤷ Try a Trial |
| Givinostat | Brazil | BR112017008945 | 2034-10-31 | ⤷ Try a Trial |
| Givinostat | Canada | CA2966005 | 2034-10-31 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
